The usefulness of immune checkpoint inhibitors among lung cancer patients with driver gene mutants
Not Applicable
- Conditions
- ung cancer
- Registration Number
- JPRN-UMIN000040789
- Lead Sponsor
- Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who excluded from clinical trials
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression free survival
- Secondary Outcome Measures
Name Time Method